Hydrocortisone for COVID-19 and Severe Hypoxia

NCT04348305 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Covid-19
Hypoxia

Interventions

DRUG: Hydrocortisone
DRUG: Sodium Chloride 9mg/mL

Sponsor

Scandinavian Critical Care Trials Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]